Literature DB >> 1941154

Simple quantification of regional myocardial uptake of fluorine-18-deoxyglucose in the fasting condition.

N Tamaki1, Y Yonekura, M Kawamoto, Y Magata, S Sasayama, N Takahashi, R Nohara, H Kambara, C Kawai, J Konishi.   

Abstract

Quantitative measurement of myocardial uptake of fluorine-18-deoxyglucose (FDG) is required for assessing tissue viability in the fasting state due to suppressed FDG uptake in the normal myocardium. A simple FDG uptake index (% dose per 100 ml tissue) has been introduced to compare with the fractional FDG uptake in 21 patients who underwent serial arterial blood sampling (14 under fasting and 7 under post-prandial conditions) and to measure the normal range in each myocardial segment in the study of 10 normal subjects (all in the fasting condition). Since the integral of plasma FDG values correlated with the body-weight corrected injected FDG dose (r = 0.82), an excellent correlation was observed between the FDG uptake index and the fractional FDG uptake (r = 0.98) in the fasting condition. In addition, the FDG uptake index correlated well with the regional metabolic rate of glucose calculated with the Patlak graphic analysis (r = 0.99). But this correlation was different in the postprandial condition and in the fasting condition in diabetic patients. In the study of normal subjects, the FDG uptake index was slightly higher in the lateral and inferior segments, as compared to the septal and anterior segments (p less than 0.05, each). We conclude that the FDG uptake index is considered as a simple and reliable parameter for quantitative assessment of myocardial FDG uptake in the nondiabetic patients in the fasting condition. Since its uptake was heterogeneous, FDG uptake should be carefully evaluated for assessing myocardial viability by comparing normal values in each segment.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1941154

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  14 in total

1.  Myocardial oxidative metabolism in normal subjects in fasting, glucose loading and dobutamine infusion states.

Authors:  N Tamaki; Y Magata; N Takahashi; M Kawamoto; T Torizuka; Y Yonekura; S Nishizawa; N Sadato; E Tadamura; S Ono
Journal:  Ann Nucl Med       Date:  1992-11       Impact factor: 2.668

2.  Simple method to quantify myocardial glucose metabolism from MB ratio in myocardial FDG PET.

Authors:  J Nishikawa; T Ohtake; I Yokoyama; T Watanabe; T Momose; Y Sasaki
Journal:  Ann Nucl Med       Date:  1996-08       Impact factor: 2.668

3.  On myocardial perfusion, metabolism, and viability.

Authors:  C L Hansen; A Rastogi; R Sangrigoli
Journal:  J Nucl Cardiol       Date:  1998 Mar-Apr       Impact factor: 5.952

4.  Quantitative analysis of myocardial glucose utilization in patients with left ventricular dysfunction by means of 18F-FDG dynamic positron tomography and three-compartment analysis.

Authors:  Koichi Morita; Chietsugu Katoh; Keiichiro Yoshinaga; Kazuyuki Noriyasu; Megumi Mabuchi; Takahiro Tsukamoto; Hiroyuki Kageyama; Tohru Shiga; Yuji Kuge; Nagara Tamaki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-03-18       Impact factor: 9.236

5.  A simple method for measuring glucose utilization of insulin-sensitive tissues by using the brain as a reference.

Authors:  H Namba; K Nakagawa; M Iyo; K Fukushi; T Irie
Journal:  Eur J Nucl Med       Date:  1994-03

6.  Clinical significance of augmented fluorine-18 deoxyglucose uptake in remote normoperfused myocardium in patients with acute coronary syndrome under fasting conditions.

Authors:  A Nakano; J D Lee; H Shimizu; Y Yonekura; T Ueda
Journal:  J Nucl Cardiol       Date:  2000 Sep-Oct       Impact factor: 5.952

7.  2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography sensitivity to serum glucose: a survey and diagnostic applications.

Authors:  Joseph A Thie; Gary T Smith; Karl F Hubner
Journal:  Mol Imaging Biol       Date:  2005 Sep-Oct       Impact factor: 3.488

8.  Factors affecting myocardial 2-[F-18]fluoro-2-deoxy-D-glucose uptake in positron emission tomography studies of normal humans.

Authors:  Y Choi; R C Brunken; R A Hawkins; S C Huang; D B Buxton; C K Hoh; M E Phelps; H R Schelbert
Journal:  Eur J Nucl Med       Date:  1993-04

9.  Combined study with I-123 fatty acid and thallium-201 to assess ischemic myocardium: comparison with thallium redistribution and glucose metabolism.

Authors:  M Kawamoto; N Tamaki; Y Yonekura; E Tadamura; Y Fujibayashi; Y Magata; R Nohara; S Sasayama; K Ikekubo; H Kato
Journal:  Ann Nucl Med       Date:  1994-02       Impact factor: 2.668

Review 10.  Imaging and modeling of myocardial metabolism.

Authors:  Sebastian Obrzut; Neema Jamshidi; Afshin Karimi; Ulrika Birgersdotter-Green; Carl Hoh
Journal:  J Cardiovasc Transl Res       Date:  2010-02-25       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.